4
Changes in Ownership
Edgewise Therapeutics, Inc. Filed Acc 0001562180-24-006261
Options or other derivatives
- Chief Scientific Officer acquired 161,875 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Russell Alan J · Chief Scientific Officer
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-08-12 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +138,750 | 138,750 | D |
| 2024-08-12 | Grant or award : show line 2 in the form Restricted Stock Units | +23,125 | 23,125 | D |
Loading xslF345X05/primarydocument.xml…